rs10804920 — TP63 TP63 oocyte apoptosis checkpoint variant

Intronic variant in TP63 (p63), the master DNA-damage checkpoint gene in primordial follicle oocytes; the T allele is associated with later age at natural menopause, reflecting better oocyte quality control and preservation of the ovarian reserve over time

See your personal result for TP63

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

TP63 — The Oocyte DNA Damage Guardian That Governs Your Ovarian Aging Clock

Every woman is born with her entire lifetime supply of eggs already formed. These primordial follicle oocytes sit in meiotic arrest, sometimes for decades, under constant threat from DNA damage accumulating over time — from metabolic byproducts, environmental toxins, radiation, and the simple passage of years. The protein that decides which of these oocytes survive and which are eliminated is TAp63α, an isoform of the p53 family member TP6311 TAp63α, an isoform of the p53 family member TP63
TAp63α (Tumor Protein p63, alpha isoform) is expressed at exceptionally high levels in primordial follicle oocytes and acts as the transcriptional master regulator of genome integrity in this cell type. rs10804920 is an intronic variant within the TP63 gene on chromosome 3. In a landmark genome-wide association study, the T allele at this variant was associated with significantly later age at natural menopause — a signal that reflects better lifetime preservation of the ovarian follicle pool.

The Mechanism

TAp63α patrols primordial oocytes for unresolved DNA damage. In its inactive state it exists as a closed, dimeric structure. When checkpoint kinases detect double-strand DNA breaks — either from meiotic recombination errors or environmental genotoxic damage — CHK2 phosphorylates TAp63α first (priming), and then CK1 provides a second, decisive phosphorylation that opens the protein into its active tetrameric form22 CHK2 phosphorylates TAp63α first (priming), and then CK1 provides a second, decisive phosphorylation that opens the protein into its active tetrameric form
This sequential two-kinase activation model was established by structural biology studies at Goethe University Frankfurt. The activated TAp63α tetramer then functions as a transcription factor, driving expression of pro-apoptotic genes Puma and Noxa33 Puma and Noxa
PUMA (p53 upregulated modulator of apoptosis) and NOXA are BCL-2 family proteins that release BAX/BAK to execute the mitochondrial apoptosis program. The result: the oocyte eliminates itself before its damaged DNA can be passed to an embryo.

The rs10804920 variant is intronic, meaning it does not alter the TAp63α protein sequence directly. Instead, it likely acts as a regulatory variant affecting TAp63α expression levels or isoform balance in primordial follicle oocytes — the tissue where TP63 expression is concentrated. The T allele (associated with later menopause) may reflect fine-tuned checkpoint activity that better distinguishes reparable from irreparable damage, preserving more healthy oocytes over time. The exact regulatory mechanism at this locus remains to be characterized.

The Evidence

The primary evidence comes from a 2021 genome-wide association study published in Nature by Ruth, Day, and colleagues44 2021 genome-wide association study published in Nature by Ruth, Day, and colleagues
Genetic insights into biological mechanisms governing human ovarian ageing. Nature 596:393-397, 2021, analysing age at natural menopause in approximately 200,000 women of European ancestry with replication in additional cohorts. rs10804920-T was identified as a genome-wide significant locus (p = 7×10⁻¹⁹) with a beta of 0.076 years per T allele — meaning each copy of the T allele is associated with approximately 1 month of later menopause timing. Women carrying TT (two protective T alleles) would be expected to experience menopause approximately 2 months later than CC homozygotes at this locus alone, reflecting cumulative effects across a lifetime of oocyte quality control.

The biological plausibility of TP63 as an ovarian aging determinant is exceptionally strong. Bolcun-Filas et al. demonstrated in Science (2014) that ablating the checkpoint kinase CHK2 completely reverses female infertility caused by either meiotic defects or ionizing radiation55 Bolcun-Filas et al. demonstrated in Science (2014) that ablating the checkpoint kinase CHK2 completely reverses female infertility caused by either meiotic defects or ionizing radiation
Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway. Science 343:533-536, proving that the CHK2→p63 axis is the dominant pathway eliminating damaged oocytes. Kerr et al. (Mol Cell, 2012) further showed that γ-irradiated female mice lacking Puma (the TAp63 downstream target) retain their fertility and produce healthy offspring at the same rate as unirradiated controls66 Kerr et al. (Mol Cell, 2012) further showed that γ-irradiated female mice lacking Puma (the TAp63 downstream target) retain their fertility and produce healthy offspring at the same rate as unirradiated controls
DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. Mol Cell 48:343-352, establishing TAp63→Puma/Noxa as the mechanistically proven link between DNA damage exposure and ovarian reserve depletion.

Practical Implications

Because TP63 checkpoint activity is central to how oocyte DNA damage translates into follicle loss, exposures that increase DNA damage burden in primordial oocytes are directly relevant to this locus: ionizing radiation (medical scans, occupational exposure), tobacco smoke, certain chemotherapy agents, and persistent organic pollutants are documented genotoxic stressors for the ovary. Reducing unnecessary exposure lowers the signal reaching the TP63 checkpoint, which translates to slower reserve depletion over the reproductive lifespan.

Two supplements have documented evidence for reducing oocyte DNA damage upstream of the checkpoint. CoQ10 (ubiquinol form) suppresses DNA damage and apoptosis in aged oocytes by restoring mitochondrial function and reducing reactive oxygen species77 suppresses DNA damage and apoptosis in aged oocytes by restoring mitochondrial function and reducing reactive oxygen species
Zhang et al. 2019, Free Radical Biology and Medicine, and melatonin enhances DNA double-strand break repair (NHEJ pathway) in oocytes during prophase arrest, reducing the γ-H2AX damage signal and preserving spindle integrity88 enhances DNA double-strand break repair (NHEJ pathway) in oocytes during prophase arrest, reducing the γ-H2AX damage signal and preserving spindle integrity
Leem et al. 2019, Journal of Pineal Research. Both act upstream of the TAp63 checkpoint — by reducing the quantity of DNA damage that triggers it, fewer oocytes reach the apoptotic threshold.

Interactions

CHK2 pathway variants (ATM, CHEK2): The CHK2→TAp63 axis that activates p63 is itself regulated by upstream DNA damage sensor kinases. Variants in ATM (rs1801516) or CHEK2 (rs17879961) that affect checkpoint kinase activity would modulate how efficiently DNA damage is transmitted to TAp63. Women carrying unfavorable genotypes at both a TP63 regulatory variant and an upstream kinase variant (ATM, CHK2) may have an amplified or attenuated response to genotoxic exposures compared to either variant alone — a compound action candidate warranting dedicated analysis when both loci are in the database.

rs116098458 (TP63 regulatory variant): Other intronic and regulatory variants within TP63 may influence TAp63α expression in primordial follicle oocytes differently from rs10804920. The combined effect of multiple TP63 regulatory variants on checkpoint stringency has not yet been characterised in the literature.

Genotype Interpretations

What each possible genotype means for this variant.

CC Standard Checkpoint Normal

Common genotype — baseline TP63 checkpoint activity and typical ovarian aging trajectory

The Ruth et al. 2021 GWAS identifies the T allele as associated with later menopause (beta = +0.076 years/allele), so CC is the reference genotype against which T-allele effects are measured. Age at natural menopause averages around 50–51 years in European-ancestry women. CC carriers cluster around this population mean.

Individual variation in actual menopause timing is dominated by lifestyle, cumulative genotoxic exposures, and variants at many other loci — rs10804920 is one of 290+ genome-wide significant hits identified in the same study, each contributing a modest increment. For CC carriers, the TP63 locus does not confer additional protection but is not a source of elevated risk compared to the population average.

CT One Protective Allele Beneficial

One T allele — mildly favorable ovarian aging trajectory at this locus

The GWAS signal at rs10804920 is highly significant and well-replicated, but the per-allele effect of ~0.076 years is modest relative to the total variance in menopause timing across individuals (~4–7 years standard deviation). At this locus, CT confers roughly half the protective signal of TT.

The most meaningful context for this genotype is cumulative — in combination with other protective ovarian reserve variants, an AMH trajectory in the normal range, and low genotoxic exposure history. AMH levels, antral follicle count, family history of early menopause, and environmental exposures all contribute substantially to realized ovarian longevity. rs10804920-CT is a favorable genetic element that adds a small increment.

Genotoxic exposures that increase DNA damage in primordial follicles (ionizing radiation, tobacco carcinogens, certain organic solvents) can override genetic protective factors by supplying a higher damage signal to the TAp63 checkpoint and accelerating follicle depletion independent of genotype.

TT Dual Protective Alleles Beneficial

Two T alleles — most favorable TP63 checkpoint configuration at this locus; associated with later menopause timing

TT is the most protective genotype at rs10804920, with the maximal T-allele effect on ovarian aging at this locus. The TP63 gene encodes TAp63α — a p53 family transcription factor that eliminates primordial follicle oocytes bearing unresolved DNA double-strand breaks via the CHK2→TAp63→Puma/Noxa apoptosis cascade, established across multiple high-impact mechanistic studies (Bolcun-Filas 2014 Science, Kerr 2012 Mol Cell, Tuppi 2018 Nat Struct Mol Biol).

A more favorable checkpoint configuration in TT carriers likely means fewer oocytes are lost to over-activation of the apoptosis pathway relative to the actual burden of irreparable DNA damage, preserving a larger functional follicle pool over time and contributing to later menopause. The absolute effect per allele is modest (~1 month), but the TT genotype represents the optimal configuration at this locus.

Importantly, this genetically favorable background does not override the effect of heavy genotoxic exposure. Tobacco smoke, ionizing radiation, and certain persistent organic pollutants supply DNA damage directly to primordial oocytes, activating the same TAp63 checkpoint regardless of regulatory genotype. Protecting the favorable checkpoint environment means keeping the incoming DNA damage signal low.

Later menopause timing is independently associated with lower cardiovascular disease risk, reduced osteoporosis risk, and a longer fertile window — the TT genotype at this locus contributes a small increment to these broader outcomes.